tiprankstipranks
Relmada Therapeutics (RLMD)
NASDAQ:RLMD

Relmada Therapeutics (RLMD) Similar Stocks

281 Followers

Other Large Cap Stocks Paying Dividends

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Protagonist Therapeutics
$2.09B
14.52
77.75%
5 Buy
0 Hold
0 Sell
Strong Buy
Avadel Pharmaceuticals
$1.56B
-8.80
16.80%
6 Buy
0 Hold
0 Sell
Strong Buy
Alnylam Pharma
$30.08B
-88.65
23.66%
14 Buy
6 Hold
0 Sell
Moderate Buy
Karyopharm Therapeutics
$110.91M
-0.70
-46.38%
5 Buy
1 Hold
0 Sell
Strong Buy
Relmada Therapeutics
$125.52M
-1.33
43.94%
2 Buy
0 Hold
1 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
PTGX
Protagonist Therapeutics
35.55
15.97
81.56%
AVDL
Avadel Pharmaceuticals
16.20
2.79
20.81%
ALNY
Alnylam Pharma
237.83
45.51
23.66%
KPTI
Karyopharm Therapeutics
0.89
-0.74
-45.40%
RLMD
Relmada Therapeutics
4.16
1.32
46.48%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis